KIMBERLIE TAYLOR: Open Payments
NPI 1164077384 · POTTSTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$195 in 8 payments from 4 companies in 2025. Trend: 2023 $505 · 2024 $379 · 2025 $195
Food & beverage: $195
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 4 | $89 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $57 |
| Neurocrine BioSciences, Inc. | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
Products named: FANAPT, CAPLYTA, INGREZZA, REXULTI.
Industry payments across PA — which companies pay providers there.
